Analyst firms · Stifel · STAA
Stifel STAA price target and rating history
STAAR Surgical Company (STAA) · Health Care
Stifel rates STAAR Surgical Company (STAA) Buy with a $31 price target, as of its latest action on Sep 29, 2026. It has published 3 rating actions on STAA since December 2022, including 2 upgrades and 0 downgrades. Across 5 firms with a STAA price target in the last 12 months, the median target is $27. Stifel's $31 is 15% above that.
- Current rating
- Buy
- Price target
- $31
- Median target, all firms
- $27
- Actions on STAA
- 3
Stifel price target on STAA
Every Stifel rating on STAA
- Sep 29, 2026
- Mar 11, 2024
- Dec 8, 2022
How other firms rate STAA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Stifel | Buy | $31 | Sep 29, 2026 |
| UBS | Sell | $20 | Jul 28, 2026 |
| Wedbush | Outperform | $40 | May 14, 2026 |
| Canaccord Genuity | Buy | $27 | Apr 9, 2026 |
| Morgan Stanley | Underweight | $13 | Jan 16, 2026 |
Questions about Stifel and STAA
- What is Stifel's price target for STAA?
- Stifel's latest stated price target for STAAR Surgical Company (STAA) is $31, from its action on Sep 29, 2026.
- What is Stifel's rating on STAA?
- Stifel rates STAA Buy, a bullish rating, as of Sep 29, 2026.
- When did Stifel last change its view on STAA?
- On Sep 29, 2026, Stifel upgrades to Buy from Hold, price target $31.
- How does Stifel's STAA target compare with other analysts?
- Across 5 firms with a STAA price target in the last 12 months, the median target is $27. Stifel's $31 is 15% above that.
More STAA rating histories
All Stifel ratingsSTAA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.